NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company dedicated to developing pioneering treatments for central nervous system diseases, focusing primarily on brain cancers such as glioblastoma. The company's innovative approaches seek to overcome the formidable challenge of delivering therapeutics across the blood-brain barrier, which has historically hindered effective treatment options.
Company Values
NeOnc's unique value lies in its proprietary nasal drug delivery system, which aims to enhance the effectiveness of treatments for brain cancers through a non-invasive administration method.